To solve unmet medical needs in the treatment of relapsed/refractory cancers and genetic diseases, we utilize CRISPR-mediated single or multiplex gene editing for more efficacious or safer cell therapy products...
Backed by our proprietary high efficient AAV production platform, high throughput vector engineering platform, GMP level AAV manufacturing platform, Cure Genetics is dedicated in developing new AAV based, effec...
Leveraging on superior specificity and precision of the CRISPR system, we develop cutting-edge molecular diagnostic tools, revolutionizing the field of liquid biopsy and companion diagnostics.
CureGenetics' a transformational biotechnology enterprise co-founded by the pioneer of CRISPR technology. Through the optimization of CRISPR system and its application methods, it has established the gene editing technology platform and delivery platform, focusing on the development ...
